Publications by authors named "Zhi-Yao Bai"
A UPLC-Q-TOF/MS-Based Metabolomics Study on the Effect of (Craib) B. L. Burtt Extract on Alzheimer's Disease.
Evid Based Complement Alternat Med
May 2021
A UPLC-Q-TOF/MS-based metabolomics study was carried out to explore the intervening mechanism of (Craib) B. L. Burtt (CF) extract on Alzheimer's disease (AD).
View Article and Find Full Text PDFArticle Synopsis
- Chinese yam (CY) is identified as a promising treatment for septic cardiomyopathy (SCM) due to its active components: adenosine, arbutin, and allantoin.
- The study assessed the treatment effects of these components on key physiological indicators and utilized a metabolomic approach to analyze metabolic disorders associated with SCM.
- Results indicated that adenosine and arbutin effectively contribute to the therapeutic effects of CY on SCM, with allantoin being less effective, highlighting the potential of these components as alternative treatments.
A Metabolomics-Based Strategy for the Mechanism Exploration of Traditional Chinese Medicine: Seeds Extract and Fractions as a Case Study.
Evid Based Complement Alternat Med
August 2017
A UPLC-QTOF-MS based metabolomics research was conducted to explore potential biomarkers which would increase our understanding of the model and to assess the integral efficacy of seeds extract (DS-A). Additionally, DS-A was split into five fractions in descending order of polarity, which were utilized to illustrate the mechanism together. The 26 identified biomarkers were mainly related to disturbances in phenylalanine, tyrosine, tryptophan, purine, arginine, and proline metabolism.
View Article and Find Full Text PDF